# Advapro Coronary Stent System in Coronary Artery Diseased Patients.

Study · id `cardio:ct-nct06300268` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06300268](<https://clinicaltrials.gov/study/NCT06300268>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06300268

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT06300268. Allocation not applicable; no masking; primary purpose treatment. Start 2024-06 (anticipated); primary completion 2026-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT06300268, source copy `cardio:ctgov-nct06300268-2024-03-08`, retrieved 2026-10-26)
- Planned start: 2024-06 (anticipated) (ClinicalTrials.gov record NCT06300268, source copy `cardio:ctgov-nct06300268-2024-03-08`, retrieved 2026-10-26)
- Primary completion: 2026-06 (anticipated) (ClinicalTrials.gov record NCT06300268, source copy `cardio:ctgov-nct06300268-2024-03-08`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06300268, source copy `cardio:ctgov-nct06300268-2024-03-08`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06300268-2024-03-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Advapro Coronary Stent System in Coronary Artery Diseased Patients.
- Acronym: RESTORE
- Condition: Coronary Artery Disease
- Condition: De Novo Stenosis Lesion
- Condition: Coronary Stent Implantation
- Intervention (Device): AdvaPro Sirolimus Eluting Coronary Stent System
- Lead sponsor: Advanced MedTech Solutions Pvt. Ltd.
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 99641188d3eb26f1c21733dccbd5fd5abe0b14123493af8d440c244ba86a64c6
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
